|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2000-5-11
|
|
pubmed:abstractText |
Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan was used as induction treatment in locally advanced extremity soft-tissue sarcomas for limb sparing surgery. The typical histopathological changes that occur in these tumoral masses are described in a series of 30 patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1068-9265
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
155-9
|
|
pubmed:dateRevised |
2007-7-18
|
|
pubmed:meshHeading |
pubmed-meshheading:10761796-Adolescent,
pubmed-meshheading:10761796-Adult,
pubmed-meshheading:10761796-Aged,
pubmed-meshheading:10761796-Antineoplastic Agents, Alkylating,
pubmed-meshheading:10761796-Chemotherapy, Cancer, Regional Perfusion,
pubmed-meshheading:10761796-Extremities,
pubmed-meshheading:10761796-Female,
pubmed-meshheading:10761796-Fibrosis,
pubmed-meshheading:10761796-Humans,
pubmed-meshheading:10761796-Hyperthermia, Induced,
pubmed-meshheading:10761796-Male,
pubmed-meshheading:10761796-Melphalan,
pubmed-meshheading:10761796-Middle Aged,
pubmed-meshheading:10761796-Necrosis,
pubmed-meshheading:10761796-Sarcoma,
pubmed-meshheading:10761796-Soft Tissue Neoplasms,
pubmed-meshheading:10761796-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations.
|
|
pubmed:affiliation |
Department of Pathology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Israel.
|
|
pubmed:publicationType |
Journal Article
|
